MECHELLI, ROSELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.055
AS - Asia 463
EU - Europa 84
Continente sconosciuto - Info sul continente non disponibili 38
AF - Africa 10
SA - Sud America 5
OC - Oceania 3
Totale 1.658
Nazione #
US - Stati Uniti d'America 873
TR - Turchia 355
CA - Canada 179
CN - Cina 79
IT - Italia 41
EU - Europa 36
IE - Irlanda 16
IR - Iran 15
SC - Seychelles 6
BR - Brasile 5
FI - Finlandia 5
RS - Serbia 5
UA - Ucraina 5
IN - India 4
EG - Egitto 3
GB - Regno Unito 3
PH - Filippine 3
SE - Svezia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IL - Israele 2
MK - Macedonia 2
NL - Olanda 2
NZ - Nuova Zelanda 2
AU - Australia 1
DE - Germania 1
HK - Hong Kong 1
ID - Indonesia 1
MX - Messico 1
NG - Nigeria 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 1.658
Città #
San Mateo 361
Kocaeli 352
Toronto 177
Wilmington 99
Houston 75
Beijing 69
Lawrence 65
Princeton 65
Fairfield 31
Ashburn 30
Woodbridge 19
Ann Arbor 16
Los Angeles 14
Tehran 14
Cambridge 13
Chandler 13
Seattle 9
Redwood City 7
Rome 6
West Jordan 6
Belgrade 5
Dublin 5
Helsinki 5
Varedo 5
Kyiv 4
Shanghai 4
Andover 3
Florence 3
Istanbul 3
Las Vegas 3
Livermore 3
Makati City 3
Pesaro 3
Rockville 3
Fontebuona 2
Jerusalem 2
Pavia 2
Piemonte 2
Redmond 2
San Francisco 2
Shrewsbury 2
Trapani 2
Arraiján 1
Bangkok 1
Boardman 1
Carol Stream 1
Chaoyang 1
Clearwater 1
Darmstadt 1
Des Moines 1
Durham 1
Guangzhou 1
Hanoi 1
Huddinge 1
Markham 1
Miranda 1
Nanchang 1
Napoli 1
New York 1
Ningbo 1
Philadelphia 1
Royersford 1
Rubano 1
San Salvador 1
Suffern 1
São Paulo 1
Terracina 1
Trento 1
Washington 1
Wenzhou 1
Zhengzhou 1
Totale 1.538
Nome #
Vaccines in multiple sclerosis. The experience of BCG vaccination 45
Varianti genotipiche del virus di Epstein Barr e loro usi come possibili predittori di rischio, biomarcatori e target terapeutici nella sclerosi multipla 43
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis 41
Transciptome of B lymphocytes in multiple sclerosis 41
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: the Case of Edaravone 38
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 37
Superstuctural features of telomeric chromatin 35
IFN-β and multiple sclerosis: From etiology to therapy and back 35
Interferon-b therapy targets memory B cells of multiple sclerosis patients: investigation of the mechanism 33
Multiple sclerosis: pharmacogenomics and personalised drug treatment 33
Multiple sclerosis etiology: beyond genes and environment 32
Telomeric nucleosomes are intrinsically mobile 32
Epstein-Barr virus genetic variants are associated with multiple sclerosis 31
Effects of Interferon-beta therapy on the expression of Epstein-Barr virus transcripts in PBMC of patients with Relapsing-Remitting Multiple Sclerosis 31
Epigenetic reprogramming in peripheral mononuclear cells from multiple sclerosis patients 31
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis 30
Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis 30
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease 30
Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis 30
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 30
Telomeric nucleosomes organization: atomic force microscopy imaging and theoretical modeling 29
IFN-beta therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients 29
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effects 29
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells 29
Increased CD8(+) T cell responses to apoptotic T cell-associated antigens in multiple sclerosis 29
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients 29
Organization of Telomeric Nucleosomes: Atomic Force Microscopy Imaging and Theoretical Modeling 28
Chemical Elements and Oxidative Status in Neuroinflammation 28
Association between vaccines and neuroinflammation. time, risks, and benefits 28
The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology 28
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 28
Characterization of Epstein-Barr virus genotypes in multiple sclerosis 27
The response to Toll-like receptor stimulation is impaired in plasmacytoid dendritic cells of multiple sclerosis patients undergoing interferon-b therapy 27
Large scale agent-based modeling of the humoral and cellular immune response 27
Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 27
GENOMIC AND PROTEOMIC ANALYSIS OF CD8+ TCELL SUBSETS IN MONOZYGOTIC TWIN PAIRS DISCORDING FOR MULTIPLE SCLEROSIS 26
IFN-β and Multiple Sclerosis. from etiology to therapy and back 26
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study 26
Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins 26
Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood 26
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets 26
Increased circulating levels of vitamin D binding protein in MS patients 25
Genome-Wide Multiple Sclerosis Association Data and Coagulation 25
Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases 25
EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy 25
Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins 24
Acetylated nucleosome assembly on telomeric DNAs 24
The role of sequence dependent DNA superstructural features in chromatin organization 23
arsenical c-glucoside derivatives with promising antitumor activity 23
CD28 individual signals amplify pro-inflammatory cytokine production in relapse-remitting multiple sclerosis T lymphocytes 23
Evidence for detrimental cross interactions between reactive oxygen and nitrogen species in Leber's hereditary optic neuropathy cells 22
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients 22
Intestinal Permeabiliy in Relapsing-Remitting Multiple Sclerosis 21
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis 21
PS1-009. TLR responsiveness of B cells is modulated in patients with multiple sclerosis following IFN-β therapy 20
CD161(high) CD8(+)T cells bear pathogenetic potential in multiple sclerosis 20
Geographic population structure in Epstein-Barr Virus revealed by comparative genomics 19
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 19
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes 17
A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors 14
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases 11
Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis 10
Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study 9
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? 9
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Dimethylfumarate 7
Viruses and neuroinflammation in multiple sclerosis 4
Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain 2
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot Study 2
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome 1
Totale 1.733
Categoria #
all - tutte 16.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020182 0 16 20 2 15 3 2 2 5 23 53 41
2020/2021586 20 39 21 0 28 34 16 8 11 17 358 34
2021/2022649 1 177 187 2 4 0 92 66 7 105 6 2
2022/2023187 144 1 6 3 4 6 3 7 1 3 6 3
2023/202477 4 1 1 4 5 33 4 4 0 19 2 0
Totale 1.733